Cargando…
Description of a CSF-Enriched miRNA Panel for the Study of Neurological Diseases
Background: The study of circulating miRNAs in CSF has gained tremendous attention during the last years, as these molecules might be promising candidates to be used as biomarkers and provide new insights into the disease pathology of neurological disorders. Objective: The main aim of this study was...
Autores principales: | Muñoz-San Martín, María, Gomez, Imma, Miguela, Albert, Belchí, Olga, Robles-Cedeño, René, Quintana, Ester, Ramió-Torrentà, Lluís |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305419/ https://www.ncbi.nlm.nih.gov/pubmed/34206241 http://dx.doi.org/10.3390/life11070594 |
Ejemplares similares
-
miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis
por: Muñoz-San Martín, María, et al.
Publicado: (2022) -
Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions
por: Muñoz-San Martín, María, et al.
Publicado: (2019) -
Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives
por: Bravo, Gary Álvarez, et al.
Publicado: (2022) -
Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors
por: Coll-Martinez, Clàudia, et al.
Publicado: (2023) -
Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis
por: Coll‐Martinez, Clàudia, et al.
Publicado: (2021)